Tumor necrosis and complete resection has significant impacts on survival in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma

Tumor necrosis (TN) is associated with worse prognosis in several solid cancers. Whether TN predicts poor outcome in natural killer cell / T cell lymphoma (NKTCL) is unclear. We investigated the clinical impact of TN on survival and other novel prognostic parameters in upper aero-digestive tract (UA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget 2017-10, Vol.8 (45), p.79337-79346
Hauptverfasser: Song, Moo-Kon, Chung, Joo-Seop, Yhim, Ho-Young, Lim, Sung-Nam, Kim, Seong-Jang, Han, Yeon-Hee, Shim, Hye-Kyung, Jung, Sung-Hoon, Lee, Je-Jung, Yang, Deok-Hwan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Tumor necrosis (TN) is associated with worse prognosis in several solid cancers. Whether TN predicts poor outcome in natural killer cell / T cell lymphoma (NKTCL) is unclear. We investigated the clinical impact of TN on survival and other novel prognostic parameters in upper aero-digestive tract (UAT) NKTCL of 100 patients with limited stage. TN was significantly associated with poor performance status ( = 0.049), high Korean Prognostic Index score ( = 0.024), high C-reactive protein/albumin ratio ( = 0.003), higher maximum standard uptake value on positron emission tomography/computed tomography (PET/CT) ( = 0.008) and higher metabolic tumor volume (MTV) on PET/CT ( < 0.001). In univariate and multivariate analyses, progression-free survival and overall survival were independently associated with High MTV status ( = 0.001, = 0.032), TN ( = 0.018, = 0.009), local tumor invasiveness ( = 0.007, = 0.035), complete resection ( = 0.020, = 0.028) and regional lymph node involvement ( < 0.001, < 0.001). TN and complete resection are concluded to be novel independent prognostic factors in patients with UAT NKTCL.
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.18107